Daniel Baker, M.D., will join Cue Biopharma's executive team as interim chief development officer (CDO), effective Monday, November 25, 2024Anish Suri, Ph.D., president & chief scientific officer (CSO ...

Norton West Louisville Hospital opened its doors to patients Monday, Nov. 11, giving residents of West Louisville access to ...

Bell has accepted the roles of executive medical director of the Cancer Institute and director of the Earle A. Chiles ...

The EFTISARC-NEO trial, with a data cut-off of 20 October 2024, also showed 71.4% of patients achieved a pathologic response ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.

Explore how robotic-assisted surgeries in India enhance precision, reduce recovery time, and improve patient care.

Propelled by personal tragedy, Dr. Charles Vialotti cares for the dying 15+ hours a day at Villa Marie Claire hospice.

Dr Hariharan (49), an Assistant Professor at the college, was assaulted by a patient named Bharath, who had been receiving treatment in the hospital for the past month.

Cardinal Health has entered into definitive agreements to acquire two companies as the medical supply firm and drug ...

Since technology is not going anywhere and does more good than harm, adapting is the best course of action. That is where The ...